Verition Fund Management’s Madrigal Pharmaceuticals MDGL Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.31M | Buy |
4,320
+296
| +7% | +$89.6K | 0.01% | 1693 |
|
2025
Q1 | $1.33M | Buy |
4,024
+24
| +0.6% | +$7.95K | 0.01% | 1451 |
|
2024
Q4 | $1.23M | Hold |
4,000
| – | – | ﹤0.01% | 1430 |
|
2024
Q3 | $849K | Hold |
4,000
| – | – | ﹤0.01% | 1411 |
|
2024
Q2 | $1.12M | Hold |
4,000
| – | – | 0.01% | 1106 |
|
2024
Q1 | $1.07M | Sell |
4,000
-29
| -0.7% | -$7.74K | 0.01% | 1116 |
|
2023
Q4 | $932K | Buy |
4,029
+29
| +0.7% | +$6.71K | 0.01% | 926 |
|
2023
Q3 | $584K | Sell |
4,000
-1,302
| -25% | -$190K | 0.01% | 1114 |
|
2023
Q2 | $1.22M | Buy |
5,302
+325
| +7% | +$75.1K | 0.02% | 742 |
|
2023
Q1 | $1.21M | Buy |
4,977
+2,798
| +128% | +$678K | 0.02% | 794 |
|
2022
Q4 | $632K | Sell |
2,179
-2,442
| -53% | -$709K | 0.01% | 928 |
|
2022
Q3 | $300K | Sell |
4,621
-719
| -13% | -$46.7K | ﹤0.01% | 1726 |
|
2022
Q2 | $382K | Buy |
+5,340
| New | +$382K | 0.01% | 1537 |
|
2021
Q3 | – | Sell |
-2,815
| Closed | -$274K | – | 1899 |
|
2021
Q2 | $274K | Buy |
+2,815
| New | +$274K | ﹤0.01% | 1253 |
|
2020
Q1 | – | Sell |
-2,410
| Closed | -$220K | – | 768 |
|
2019
Q4 | $220K | Sell |
2,410
-508
| -17% | -$46.4K | ﹤0.01% | 818 |
|
2019
Q3 | $252K | Buy |
+2,918
| New | +$252K | 0.01% | 746 |
|
2018
Q4 | – | Sell |
-1,839
| Closed | -$394K | – | 1005 |
|
2018
Q3 | $394K | Buy |
+1,839
| New | +$394K | 0.01% | 865 |
|
2015
Q3 | – | Sell |
-807
| Closed | -$63K | – | 626 |
|
2015
Q2 | $63K | Buy |
+807
| New | +$63K | 0.01% | 555 |
|
2015
Q1 | – | Sell |
-350
| Closed | -$33K | – | 436 |
|
2014
Q4 | $33K | Sell |
350
-215
| -38% | -$20.3K | 0.01% | 316 |
|
2014
Q3 | $60K | Buy |
+565
| New | +$60K | 0.01% | 639 |
|
2013
Q3 | – | Sell |
-316
| Closed | -$55K | – | 598 |
|
2013
Q2 | $55K | Buy |
+316
| New | +$55K | 0.01% | 513 |
|